Ravindra W. Tejwani

Person

New Brunswick, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Formulations of pimavanserin
- Patent number 11,452,721
- Issue date Sep 27, 2022
- Acadia Pharmaceuticals Inc.
- Ravindra Tejwani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 9,198,925
- Issue date Dec 1, 2015
- Astrazeneca AB
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,716,251
- Issue date May 6, 2014
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,361,972
- Issue date Jan 29, 2013
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 8,221,786
- Issue date Jul 17, 2012
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations containing an SGLT2 inhibitor
- Patent number 7,851,502
- Issue date Dec 14, 2010
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 7,659,261
- Issue date Feb 9, 2010
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Patent number 7,659,262
- Issue date Feb 9, 2010
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 7,524,832
- Issue date Apr 28, 2009
- Bristol-Myers Squibb Co.
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Patent number 6,855,702
- Issue date Feb 15, 2005
- Bristol-Myers Squibb Company
- John J. Venit
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Patent number 6,670,344
- Issue date Dec 30, 2003
- Bristol-Myers Squibb Company
- John J. Venit
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FORMULATIONS OF PIMAVANSERIN
- Publication number 20220193057
- Publication date Jun 23, 2022
- ACADIA Pharmaceuticals Inc.
- Ravindra Tejwani
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATIONS OF PIMAVANSERIN
- Publication number 20210283118
- Publication date Sep 16, 2021
- ACADIA Pharmaceuticals Inc.
- Ravindra Tejwani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR
- Publication number 20140243262
- Publication date Aug 28, 2014
- AstraZeneca AB
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing An SGLT2 Inhibitor
- Publication number 20130129819
- Publication date May 23, 2013
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing an SGLT2 Inhibitor
- Publication number 20120263786
- Publication date Oct 18, 2012
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Formulations Containing an SGLT2 Inhibitor
- Publication number 20110064801
- Publication date Mar 17, 2011
- Bristol-Myers Squibb Company
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Sa...
- Publication number 20090186857
- Publication date Jul 23, 2009
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR
- Publication number 20080234366
- Publication date Sep 25, 2008
- Bristol-Myers Squibb
- Dilbir S. Bindra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...
- Publication number 20070270617
- Publication date Nov 22, 2007
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060172980
- Publication date Aug 3, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060166942
- Publication date Jul 27, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20060165772
- Publication date Jul 27, 2006
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20050153939
- Publication date Jul 14, 2005
- Bristol-Myers Squibb Company
- John J. Venit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20040054212
- Publication date Mar 18, 2004
- Bristol-Myers Squibb Company
- John J. Venit
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...
- Publication number 20020072507
- Publication date Jun 13, 2002
- John J. Venit
- C07 - ORGANIC CHEMISTRY

Ravindra W. Tejwani

Person

Patents Grantslast 30 patents

Formulations of pimavanserin

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Pharmaceutical formulations containing an SGLT2 inhibitor

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Patents Applicationslast 30 patents

FORMULATIONS OF PIMAVANSERIN

FORMULATIONS OF PIMAVANSERIN

PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR

Pharmaceutical Formulations Containing An SGLT2 Inhibitor

Pharmaceutical Formulations Containing an SGLT2 Inhibitor

Pharmaceutical Formulations Containing an SGLT2 Inhibitor

Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Sa...

PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR

Combretastatin A-4 phosphate prodrug mono- and di-organic amine sal...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...

Combretastatin A-4 phosphate prodrug mono-and di-organic amine salt...